First‐line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes

Abstract Classical Hodgkin lymphoma (cHL) is curable in 90% of cases, but advanced stage patients who do not respond well to first‐line (1L) therapy have poorer outcomes. This retrospective study examines patient characteristics, treatment patterns, clinical outcomes, and safety management of 1L cHL...

Full description

Bibliographic Details
Main Authors: Abraham Avigdor, Fabrizio Trinchese, Francois Gavini, Nawal Bent‐Ennakhil, Mehul Dalal, Athanasios Zomas, Sharmeen Gettner Broun, Guido Gini
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:eJHaem
Subjects:
Online Access:https://doi.org/10.1002/jha2.426